Search results for "150"

showing 10 items of 973 documents

Protein misfolding, amyotrophic lateral sclerosis and guanabenz: Protocol for a phase II RCT with futility design (ProMISe trial)

2017

IntroductionRecent studies suggest that endoplasmic reticulum stress may play a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS) through an altered regulation of the proteostasis, the cellular pathway-balancing protein synthesis and degradation. A key mechanism is thought to be the dephosphorylation of eIF2α, a factor involved in the initiation of protein translation. Guanabenz is an alpha-2-adrenergic receptor agonist safely used in past to treat mild hypertension and is now an orphan drug. A pharmacological action recently discovered is its ability to modulate the synthesis of proteins by the activation of translational factors preventing misfolded protein accumula…

0301 basic medicineOncologyPathologyamyotrophic lateral sclerosisamyotrophic lateral sclerosis; motor neurone disease; neuromuscular disease; randomized clinical trial guanabenz; unfolded protein response; adrenergic alpha-2 receptor agonist s; age of onset; amyotrophic lateral sclerosis; disease progression; double-blind method; endoplasmic reticulum stress; guanabenz; humans; italy; medical futility; neuroprotective agents; proteostasis deficienciesamyotrophic lateral sclerosis; motor neurone disease; neuromuscular disease; randomized clinical trial guanabenz; unfolded protein response; Medicine (all)randomized clinical trial guanabenzHelsinki declaration0302 clinical medicineProtocolAdrenergic alpha-2 Receptor Agonists1506Amyotrophic lateral sclerosisAge of OnsetGuanabenzMedicine (all)amyotrophic lateral sclerosis; motor neurone disease; neuromuscular disease; randomized clinical trial guanabenz; unfolded protein responseNeurodegenerationamyotrophic lateral sclerosis; motor neurone disease; neuromuscular disease; randomized clinical trial guanabenz; unfolded protein response;amyotrophic lateral sclerosis; guanabenz; motor neurone disease; neuromuscular disease; randomized clinical trial; unfolded protein response; Adrenergic alpha-2 Receptor Agonists; Age of Onset; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Endoplasmic Reticulum Stress; Guanabenz; Humans; Italy; Medical Futility; Neuroprotective Agents; Proteostasis DeficienciesGeneral Medicineunfolded protein responseEndoplasmic Reticulum StressRiluzoleNeuroprotective AgentsNeurologyTolerabilityItalyDisease Progression1713GuanabenzMedical Futilitymedicine.drugmedicine.medical_specialtyamyotrophic lateral sclerosis; motor neurone disease; neuromuscular disease; randomized clinical trial guanabenz; unfolded protein response; Adrenergic alpha-2 Receptor Agonists; Age of Onset; Amyotrophic Lateral Sclerosis; Disease Progression; Double-Blind Method; Endoplasmic Reticulum Stress; Guanabenz; Humans; Italy; Medical Futility; Neuroprotective Agents; Proteostasis Deficiencies; Medicine (all)Neuroprotection03 medical and health sciencesmotor neurone diseaseDouble-Blind MethodInternal medicinemedicineHumansProteostasis Deficienciesbusiness.industryAmbientaleneuromuscular diseaserandomized clinical trialmedicine.diseaseClinical trial030104 developmental biologybusiness030217 neurology & neurosurgery
researchProduct

Assessment of genetically modified maize 1507 × NK603 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐008)

2018

International audience; Following the submission of application EFSA-GMO-RX-008 under Regulation (EC) No 1829/2003 from Pioneer Hi-Bred International, Inc. and Dow AgroSciences LLC, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect-resistant, herbicide-tolerant genetically modified maize 1507 x NK603, for food and feed uses, import and processing, excluding cultivation within the EU. The data received in the context of this renewal application contained a systematic search and evaluation of literature, updated bioin…

0301 basic medicineVeterinary (miscellaneous)[SDV]Life Sciences [q-bio]Plant Science010501 environmental sciences01 natural sciencesMicrobiology[SHS]Humanities and Social Sciences03 medical and health sciences1507 × NK603[SDV.IDA]Life Sciences [q-bio]/Food engineering[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process Engineering0105 earth and related environmental sciences2. Zero hungerrenewalGmoRegulation (EC) No 1829/2003Maize030104 developmental biologyScientific Opinion[SDE]Environmental Sciences1507 x NK603ParasitologyAnimal Science and ZoologyArticles 11 and 23Food ScienceRegulation (EC) No 1829/2003
researchProduct

A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.

2018

We read with interest the article by Passamonti et al ,1 reporting the performance of two different faecal immunochemical tests (FITs) highlighting the importance of standardisation and validation of screening methodologies. Conventionally, laboratory-based FIT is the preferred approach in testing for occult blood in faeces, which includes colorectal cancer screening programmes.2–4 The potential of preserving stable faecal samples in a widely used FIT buffer for microbiome research would enable prospective microbiome studies in generally healthy subjects undergoing colorectal cancer screening. For this purpose, we evaluated faecal sample stability in the commonly used OC-Sensor (Eiken Chemi…

0301 basic medicineVeterinary medicine2312BiologySampling device03 medical and health sciencesHemoglobins0302 clinical medicineHumansMass Screening1506Microbiomecolonic microfloraEarly Detection of CancerMicrobiotaGastroenterologyHealthy subjectsIllumina miseqIon semiconductor sequencingPostScriptSample stabilityGastrointestinal Microbiome030104 developmental biologyColorectal cancer screeningMetagenomicsOccult Bloodepidemiology030211 gastroenterology & hepatologyGuaiacColorectal NeoplasmsGut
researchProduct

Transcriptome analysis revealed that a quorum sensing system regulates the transfer of the pAt megaplasmid in Agrobacterium tumefaciens.

2016

Background Agrobacterium tumefaciens strain P4 is atypical, as the strain is not pathogenic and produces a for this species unusual quorum sensing signal, identified as N-(3-hydroxy-octanoyl)-homoserine lactone (3OH,C8-HSL). Results By sequence analysis and cloning, a functional luxI-like gene, named cinI, has been identified on the At plasmid of A. tumefaciens strain P4. Insertion mutagenesis in the cinI gene and transcriptome analyses permitted the identification of 32 cinI-regulated genes in this strain, most of them encoding proteins responsible for the conjugative transfer of pAtP4. Among these genes were the avhB genes that encode a type 4 secretion system (T4SS) involved in the forma…

0301 basic medicineacylhomoserime lactoneIdentification[SDV]Life Sciences [q-bio]AgrobacteriumPlasmidePlant Rootsfluids and secretionsPlasmidSolanum lycopersicumhttp://aims.fao.org/aos/agrovoc/c_16014Expression des gènesDynamique des populationsCloning MolecularPhylogenyGeneticsbiology000 - Autres thèmeshttp://aims.fao.org/aos/agrovoc/c_27583food and beveragesAgrobacterium tumefaciensLactonehttp://aims.fao.org/aos/agrovoc/c_768[SDV] Life Sciences [q-bio]Quorum sensingT4SSConjugation GeneticPropriété biologiquehttp://aims.fao.org/aos/agrovoc/c_35128PlasmidsResearch Articlehttp://aims.fao.org/aos/agrovoc/c_4145BiotechnologyDtr systemSéquence nucléotidiqueAgrobacteriumSequence analysisMutagenesis (molecular biology technique)At plasmid03 medical and health scienceshttp://aims.fao.org/aos/agrovoc/c_4891Bacterial Proteinsstomatognathic systemhttp://aims.fao.org/aos/agrovoc/c_3081Geneticshttp://aims.fao.org/aos/agrovoc/c_1501Acylhomoserine lactoneTranscriptomicsGenehttp://aims.fao.org/aos/agrovoc/c_6111H20 - Maladies des plantesCloning[ SDV ] Life Sciences [q-bio]Bactériologiehttp://aims.fao.org/aos/agrovoc/c_27444Sequence Analysis RNATranscription géniqueConjugationGene Expression ProfilingBiologie moléculaireGene Expression Regulation Bacterialbiochemical phenomena metabolism and nutritionQuorum sensing;Agrobacterïum;At plasmid;transcriptomics;conjugation;T4SS;Dtr system;Acylhomoserine lactonebiology.organism_classificationhttp://aims.fao.org/aos/agrovoc/c_27527Quorum sensinghttp://aims.fao.org/aos/agrovoc/c_3791030104 developmental biologyAgrobacterium tumefaciensbacteriaGenetic Fitness
researchProduct

Randomised double-blind placebo-controlled intervention study on the nutritional efficacy of a food for special medical purposes (FSMP) and a dietary…

2019

ObjectiveTo assess whether the symptoms of veisalgia can be reduced by intense water supply and the intake of antioxidative supplements and plant extracts.MethodsWe performed the world’s largest randomised double-blind placebo-controlled intervention study (214 participants) on the efficacy of a food for special medical purposes (FSMP) against veisalgia symptoms. We analysed the effectiveness of: (1) an FSMP, including distinct plant extracts, vitamins and minerals, and additional (antioxidative) compounds; (2) a dietary supplement only comprising vitamins and minerals and additional (antioxidative) compounds; and (3) a placebo containing only glucose. The study followed the CONSORT (Consol…

0301 basic medicinemedicine.medical_specialtyHealth (social science)NauseaBody waterDietary supplementMedicine (miscellaneous)AlcoholPlaceboDouble blind03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicine1506nutritional treatmentlcsh:RC620-627Original ResearchNutrition and Dieteticsbusiness.industryConsolidated Standards of Reporting TrialsIntervention studieslcsh:Nutritional diseases. Deficiency diseases030104 developmental biologychemistrymedicine.symptombusiness030217 neurology & neurosurgeryBMJ Nutrition, Prevention & Health
researchProduct

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.

2017

ObjectiveCancer stem cells (CSCs) are responsible for tumour formation and spreading, and their targeting is required for tumour eradication. There are limited therapeutic options for advanced colorectal cancer (CRC), particularly for tumours carrying RAS-activating mutations. The aim of this study was to identify novel CSC-targeting strategies.DesignTo discover potential therapeutics to be clinically investigated as single agent, we performed a screening with a panel of FDA-approved or investigational drugs on primary CRC cells enriched for CSCs (CRC-SCs) isolated from 27 patients. Candidate predictive biomarkers of efficacy were identified by integrating genomic, reverse-phase protein mic…

0301 basic medicinep53DNA ReplicationCELL CYCLE CONTROLDNA damageColorectal cancerColonmedicine.medical_treatmentAntineoplastic AgentsBiologyBioinformaticsmedicine.disease_causeDNA DAMAGETargeted therapy03 medical and health sciencesCancer stem cellCell Line TumormedicineHumansCHEK11506DRUG DEVELOPMENTOligonucleotide Array Sequence AnalysisMutationCOLORECTAL CANCERSettore MED/06 - ONCOLOGIA MEDICAGastroenterologyCHEMOTHERAPYmedicine.diseaseImmunohistochemistryPrexasertib030104 developmental biologyPyrazinesCheckpoint Kinase 1MutationCancer researchNeoplastic Stem CellsPyrazolesStem cellTumor Suppressor Protein p53Colorectal NeoplasmsGut
researchProduct

Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals

2018

Objective Within the last years, there has been growing awareness of the negative repercussions of unstandardized planning, conduct and reporting of preclinical and biomedical research. Several initiatives have set the aim of increasing validity and reliability in reporting of studies and publications, and publishers have formed similar groups. Additionally, several groups of experts across the biomedical spectrum have published experience and opinion-based guidelines and guidance on potential standardized reporting. While all these guidelines cover reporting of experiments, an important step prior to this should be rigours planning and conduction of studies. The aim of this systematic revi…

0301 basic medicineprotocols & guidelinesData managementValiditylcsh:MedicineEnglish languageRigour03 medical and health sciences0302 clinical medicineEQIPD WP3 study groupProtocol1506030212 general & internal medicineInternal validitydrug evaluation preclinicalProtocol (science)Medical education630 Agriculturebusiness.industrylcsh:RGeneral MedicineBMJOS030104 developmental biologySystematic reviewPsychologybusinessInclusion (education)BMJ Open Science
researchProduct

ACTIVIDAD FÍSICA Y DISCAPACIDAD: UN ESTUDIO CUALITATIVO CON MUJERES EN UN GIMNASIO ADAPTADO

2017

Este estudio explora cómo un grupo de mujeres con discapacidad (n=6) experimentan y perciben la práctica de actividad física en un gimnasio adaptado. Se utilizaron entrevistas semi-estructuradas como instrumento de recogida de datos cualitativos y se realizó un análisis temático inductivo. Los resultados se agruparon en torno a cuatro categorías temáticas emergentes: condición física y autonomía personal; papel paliativo del ejercicio; bienestar psicológico; relación social y apoyo. Destaca la experiencia satisfactoria de las participantes, en la que predomina una valoración positiva de procesos autorregulativos, la concepción social-relacional de la actividad física, y la relevancia del gi…

030504 nursingbusiness.industryPhysical fitnessPhysical activityBienestar social. Autonomía personal. Facilitadores. Barreras.Inductive analysisQualitative propertyPersonal autonomySocial Welfare. Personal autonomy. Facilitators. Barriers.Social relationEducation03 medical and health sciences0302 clinical medicineDisabled persons (categoría M01.150)FacilitatorRelevance (information retrieval)Bem-estar social. Autonomia pessoal. Facilitadores. Barreiras.030212 general & internal medicine0305 other medical sciencePsychologybusinessSocial psychology
researchProduct

Scientific Opinion on application EFSA‐GMO‐BE‐2013‐118 for authorisation of genetically modified maize MON 87427 × MON 89034 × 1507 × MON 88017 × 591…

2017

Abstract In this opinion, the GMO Panel assessed the five‐event stack maize MON 87427 × MON 89034 ×1507 × MON 88017 × 59122 and its 25 subcombinations, independently of their origin. The GMO Panel has previously assessed the five single events combined to produce this five‐event stack maize and 11 subcombinations of these events and did not identify safety concerns. No new data on the single events or their previously assessed subcombinations, leading to modification of the original conclusions were identified. The combination of the single events and of the newly expressed proteins in the five‐event stack maize did not give rise to issues – based on the molecular, agronomic/phenotypic or c…

040301 veterinary sciencesherbicide toleranceVeterinary (miscellaneous)Context (language use)Plant ScienceGenetically modified crops010501 environmental sciencesBiologymaize01 natural sciencesMicrobiology0403 veterinary scienceEnvironmental safety0105 earth and related environmental sciencesGenetically modified maizebusiness.industryGMOAuthorizationGMO;maize;MON 87427 x MON 89034 x 1507 x MON 88017 x 59122;herbicide tolerance;insect resistance04 agricultural and veterinary sciencesFood safetyZea maysBiotechnologyGenetically modified organismMON87427xMON89034x1507xMON88017x59122Scientific OpinionSettore AGR/11 - Entomologia Generale E ApplicataMON 87427 × MON 89034 × 1507 × MON 88017 × 59122Animal Science and ZoologyParasitologyinsect resistancebusinessFood Science
researchProduct

Cognitive Biases in Pathological Health Anxiety

2016

Pathological health anxiety refers to the medically unfounded fear of suffering from a severe illness. Differences in cognitive processes related to attention, memory, and evaluation of health threat have been hypothesized to underlie pathological health anxiety. In no study, however, have researchers systematically and simultaneously assessed different cognitive biases. On the basis of the idea that multiple cognitive biases simultaneously contribute to psychopathology (the combined-cognitive-bias hypothesis), we compared 88 patients with pathological health anxiety, 52 patients with depressive disorder, and 52 healthy participants on their performance in several cognitive tasks involving…

050103 clinical psychology05 social sciencesCognitionAttentional biasCognitive bias03 medical and health sciencesClinical Psychology0302 clinical medicineddc:150hypochondriasis pathological health anxiety somatoform disorders attentional bias emotional Stroop task memory biasmedicineAnxiety0501 psychology and cognitive sciencesmedicine.symptomPsychologyPathological030217 neurology & neurosurgeryCognitive psychologyMemory biasClinical Psychological Science
researchProduct